Skip to main content
SpringerLink
Log in

The Pharmacology of Amphetamines

  • Chapter
The Pharmacology of Alcohol and Drugs of Abuse and Addiction

  • 242 Accesses

Abstract

The amphetamine molecule is chemically simple with a number of intriguing actions. Attempts to refine and emphasize desired effects and minimize the less useful effects have led to the development of derivatives of amphetamines that are of clinical, experimental, and illicit interest.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weiner, N (1985). Norepinephrine, epinephrine and the sympathomimetic amines. In Pharmacological Basis of Therapeutics, 7th Ed., Gilman A, Goodman L, Rail TW, Murad F, eds., 145–180. New York: MacMillan.

    Google Scholar 

  2. Biel JH (1970). Structure-activity relationships of amphetamine and derivatives. In Amphetamines and Related Compounds, Costa E, Garattini S, eds., p. 3. New York: Raven Press.

    Google Scholar 

  3. Gilman A, Goodman L, Rail TW, Murad F, eds. (1985). Pharmacological Basis of Therapeutics, 7th Ed. New York: Macmillan.

    Google Scholar 

  4. Bahnsen P, Jacobsen E, Thesleff H (1938). The subjective effect of beta-phenyl-isopropylamin-sulfate on normal adults. Acta Med Scand97:89–92.

    Article  CAS  Google Scholar 

  5. Jacobsen E, Wollstein A (1939). Studies on the subjective effects of the cephalo-tropic amines in men. Acta Med Scand100:159–162.

    Article  CAS  Google Scholar 

  6. Schroeder DJ, Collins WE (1974). Effects of secobarbital and D-amphetamine on tracking performance during angular acceleration. Ergonomics17 (5): 813–821.

    Article  Google Scholar 

  7. Smith GM, Beecher HK (1959). Amphetamine sulfate and athletic performance-Objective effects. JAMA170:542–557.

    CAS  Google Scholar 

  8. Cameron JS, Specht PG, Wendt GR (1965). Effects of amphetamines on moods, emotions and motivation. J Psychol61:93–121.

    PubMed  CAS  Google Scholar 

  9. . Martin WR, Sloan JW, Sapira JD, et al. (1971). Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetra-zine and methylphenidate in man. Clin Pharmacol Ther12:245–258.

    PubMed  CAS  Google Scholar 

  10. Lasagna L, Von Felsinger JM, Beecher HK (1955). Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and post addicts. JAMA157:1066–1120.

    Google Scholar 

  11. Kilbey MM, Ellinwood EH, eds. (1977). Chronic administration of stimulant drugs: Response modification. In Cocaine and Other Stimulants, pp. 410–429. New York: Plenum Press.

    Google Scholar 

  12. Griffith JD, Cavanaugh JH, Oates JA (1968). Paranoid episodes induced by drug. JAMA205: 39–40.

    Google Scholar 

  13. Ellinwood EH, Jr. (1967). Amphetamine psychosis. I. Description of the individuals and process. J Nerv Ment Dis144:273–283.

    Article  Google Scholar 

  14. Angrist B, Sathananthan G, Wilk S (1974). Amphetamine psychosis: Behavioral and biochemical aspects. J Psychiatr Res11:13–23.

    Article  PubMed  CAS  Google Scholar 

  15. Davis JM (1975). Catecholamines and psychosis. In Catecholamines and Behavior, Vol. 2, Freidhoff A J, ed. New York: Plenum Press.

    Google Scholar 

  16. Kalant O J (1966). Abuse of amphetamine-like drugs. In The Amphetamines: Toxicity and Addiction Springfield, IL: C. C. Thomas.

    Google Scholar 

  17. Prinzmetal M, Bloomberg W (1935). The use of benzedrine for the treatment of narcolepsy. JAMA105: 2051–2055.

    CAS  Google Scholar 

  18. Bell DS (1965). Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry3:701–707.

    Article  Google Scholar 

  19. Segal DS, Janowsky DS (1978). Psychostimulant-induced behavioral effects: Possible models of schizophrenia. In Psychopharmacology: A Generation of Progress, Lipton MA, DiMasco A, Killam KF, eds., p. 461. New York: Raven Press.

    Google Scholar 

  20. Connell PH (1958). Amphetamine psychosis. Maudsley Monograph No. 5. London: Oxford University Press.

    Google Scholar 

  21. Bell DS (1973). The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry29:35–40.

    PubMed  CAS  Google Scholar 

  22. National Commission on Marijuana and Drug Abuse (1973). Drug use in America: Problems in perspective. In Second Report of the National Commission on Marijuana and Drug Abuse Washington, DC: National Institute on Drug Abuse.

    Google Scholar 

  23. Mayfield DG (1979). Alcohol and affect: Experimental studies. In Alcoholism and Affective Disorders, Goodwin DW, Erickson CK, eds., pp. 99–107. New York: SP Medical and Scientific Books.

    Google Scholar 

  24. Schuckit MA (1983). Alcoholic patients with secondary depression. Am J Psychiatry140 (6): 711–714.

    PubMed  CAS  Google Scholar 

  25. Kramer JC, Fischman VS, Littlefield DC (1967). Amphetamine abuse. J Am Med Ass201:305–309.

    Article  CAS  Google Scholar 

  26. Grinspoon L, Bakalar JB (1980). Drug dependence: Nonnarcotic agents. In Comprehensive Textbook of Psychiatry, 3d Ed., Kaplan HI, Freedman AM, Sadock BJ, eds. Baltimore: Williams & Wilkins.

    Google Scholar 

  27. Strategy Council on Drug Abuse (1973). Federal Strategy for Drug Abuse and Drug Traffic Prevention, 1973. Washington, DC: U.S. Govt. Printing Office.

    Google Scholar 

  28. Canadian Medical Association (1969). Nonmedical use of drugs, with particular reference to youth. Report of the special committee on drug misuse, council on community health care, Canadian Medical Association. Can Med Assoc7101.

    Google Scholar 

  29. Knapp P (1952). Amphetamine and addiction. J Nerv Ment Dis115: 406–410.

    PubMed  CAS  Google Scholar 

  30. Rylander G (1971). Stereotype behavior in man following amphetamine abuse. Proc Eur Soc Study Drug Tox12:28–34.

    Google Scholar 

  31. Cox C, Smart RG (1970). The nature and extent of speed use in North America. Can Med Assoc J102:724–729.

    PubMed  CAS  Google Scholar 

  32. Dominic JA, Moore KE (1969). Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of a-methyltyro-sine. Psychopharmacologia(Berlin) 15: 96–101.

    CAS  Google Scholar 

  33. Creese I, Burt DR, Snyder SH (1977). Dopamine receptor binding enhancement accompanies lesions-induced behavioral supersensitivity. Science197:596–598.

    Article  PubMed  CAS  Google Scholar 

  34. Dackis CA, Gold MS (1985). Pharmacological approaches to cocaine addiction. JSubstAbuse Treat2:139–145.

    Article  PubMed  CAS  Google Scholar 

  35. Miller NS, Dackis CA, Gold MS (1987). The relationship of addiction, tolerance and dependence: A neurochemical approach. J Subst Abuse Treat4 (3–4): 197–207.

    Article  PubMed  CAS  Google Scholar 

  36. Ungerstedt U (1971). Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol Scand (Suppl)83:1–48.

    Google Scholar 

  37. Von Voigtlander PF, Moore KE (1970). Behavioral and brain catecholamine depleting actions of U-14.624, an inhibitor of dopamine-ß-hydroxylase. Proc Soc Exp Biol Med133:817.

    Google Scholar 

  38. Chiueh CC, Moore KE (1975). D-amphetamine-induced release of “newly-synthesized” and “stored” dopamine from the caudate nucleus in vitro. J Pharmacol Exp Ther192:642–653.

    PubMed  CAS  Google Scholar 

  39. Azzaro AJ, Ziance RJ, Rutledge CO (1974). The importance of neuronal intake of amines for amphetamine-induced release of 3H–norepinephrine from isolated brain tissue. J Pharmacol Exp Ther189:110–118.

    PubMed  CAS  Google Scholar 

  40. Thornburg JE, Moore KE (1973). The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Neuropharmacology12:853–866.

    Article  PubMed  CAS  Google Scholar 

  41. Russek M, Rodrigues–Zendejas AM, Teitelbaum P (1973). The action of adrenergic anorexigenic substances on rats recovered from lateral hypothalamus lesions. PhysiolBehav10:329–333.

    Article  CAS  Google Scholar 

  42. Hoebei BG (1975). Satiety: Hypothalamic stimulation, anorectic drugs, neurochemical substrates. In Hunger: Basic Mechanisms and Clinical Implications, Novin D, Wyrujicka W, Bray G, eds. New York: Raven Press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cornell University Medical College, New York Hospital-Cornell Medical Center, 21 Bloomingdale Road, 10605, New York, USA

    Norman S. Miller M.D.

Authors
  1. Norman S. Miller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York

About this chapter

Cite this chapter

Miller, N.S. (1991). The Pharmacology of Amphetamines. In: The Pharmacology of Alcohol and Drugs of Abuse and Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3044-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3044-1_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7774-3

  • Online ISBN: 978-1-4612-3044-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation